The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma’s “next generation” weight loss drug.
Related Posts
IBM shares rise 9% on earnings beat
In a statement, IBM CEO Arvind Krishna said the company has recorded $5 billion in bookings for its generative AI business.
Fed Chair Powell says central bank doesn’t ‘need to be in a hurry’ to lower interest rates further
Powell called the economy “strong overall” with a “solid” labor market and inflation that is easing but still above the Fed’s 2% goal.
Trump tells Walmart to ‘eat the tariffs’ after retailer warned it will raise prices
Trump blasted Walmart after the retailer warned it would raise prices due to tariffs.